This was not a new disclosure as the piggyback ability of the treatment was disclosed in a statement by a company(car) that was using similar ability in research for ms treatment that was on track to be investigated before covid and basically put to back of line for last 3 years. Their research was more forward as a way to developing whole cell rejuvenation not infection and showed some of the flawed assumptions ignored by research in fast track of covid drug
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.